Cancers Stocks List
Symbol | Grade | Name | Weight |
---|---|---|---|
PBE | D | PowerShares Dynamic Biotech & Genome | 15.71 |
GERM | C | ETFMG Treatments Testing and Advancements ETF | 14.79 |
CNCR | D | Loncar Cancer Immunotherapy ETF | 10.0 |
BBP | D | BioShares Biotechnology Products Fund | 9.71 |
PTH | D | Invesco DWA Healthcare Momentum ETF | 9.04 |
View all Cancers related ETFs...
Compare ETFs
Date | Stock | Signal | Type |
---|---|---|---|
2021-02-25 | ADXS | Fell Below 20 DMA | Bearish |
2021-02-25 | AGEN | Non-ADX 1,2,3,4 Bullish | Bullish Swing Setup |
2021-02-25 | AGEN | 1,2,3 Pullback Bullish | Bullish Swing Setup |
2021-02-25 | AGIO | Fell Below 20 DMA | Bearish |
2021-02-25 | AIM | 20 DMA Resistance | Bearish |
2021-02-25 | ALRN | MACD Bearish Centerline Cross | Bearish |
2021-02-25 | ALRN | Lower Bollinger Band Walk | Weakness |
2021-02-25 | ALRN | Fell Below 50 DMA | Bearish |
2021-02-25 | ATNX | 200 DMA Resistance | Bearish |
2021-02-25 | ATNX | 50 DMA Resistance | Bearish |
2021-02-25 | BCAB | New 52 Week High | Strength |
2021-02-25 | BCAB | Doji - Bearish? | Reversal |
2021-02-25 | BDX | Lower Bollinger Band Walk | Weakness |
2021-02-25 | BDX | Crossed Above 200 DMA | Bullish |
2021-02-25 | BDX | Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup |
2021-02-25 | BDXB | Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup |
2021-02-25 | BDXB | Lower Bollinger Band Walk | Weakness |
2021-02-25 | BDXB | Spinning Top | Other |
2021-02-25 | CGEN | Volume Surge | Other |
2021-02-25 | CGEN | Expansion Breakdown | Bearish Swing Setup |
2021-02-25 | CGEN | Reversal New Lows Setup | Bearish Swing Setup |
2021-02-25 | CGEN | Lower Bollinger Band Walk | Weakness |
2021-02-25 | CGEN | Wide Range Bar | Range Expansion |
2021-02-25 | CGIX | Stochastic Buy Signal | Bullish |
2021-02-25 | CGIX | 20 DMA Support | Bullish |
2021-02-25 | CLSN | 1,2,3 Pullback Bullish | Bullish Swing Setup |
2021-02-25 | CLSN | MACD Bearish Signal Line Cross | Bearish |
2021-02-25 | CLSN | Non-ADX 1,2,3,4 Bullish | Bullish Swing Setup |
2021-02-25 | CUE | 50 DMA Resistance | Bearish |
2021-02-25 | DRNA | Shooting Star Candlestick | Bearish |
2021-02-25 | DRNA | New 52 Week High | Strength |
2021-02-25 | DRNA | New 52 Week Closing High | Bullish |
2021-02-25 | DRNA | Pocket Pivot | Bullish Swing Setup |
2021-02-25 | ENOB | 20 DMA Resistance | Bearish |
2021-02-25 | ENOB | Stochastic Reached Oversold | Weakness |
2021-02-25 | EPZM | Lower Bollinger Band Walk | Weakness |
2021-02-25 | EPZM | New 52 Week Low | Weakness |
2021-02-25 | EPZM | New 52 Week Closing Low | Bearish |
2021-02-25 | EVAX | Hot IPO Pullback | Bullish Swing Setup |
2021-02-25 | FMTX | MACD Bearish Signal Line Cross | Bearish |
2021-02-25 | FMTX | Fell Below 20 DMA | Bearish |
2021-02-25 | FMTX | 50 DMA Support | Bullish |
2021-02-25 | FMTX | Bollinger Band Squeeze | Range Contraction |
2021-02-25 | GOVX | NR7 | Range Contraction |
2021-02-25 | HGEN | Fell Below 50 DMA | Bearish |
2021-02-25 | HGEN | 1,2,3 Pullback Bullish | Bullish Swing Setup |
2021-02-25 | HGEN | Stochastic Reached Oversold | Weakness |
2021-02-25 | HOOK | Cup with Handle | Other |
2021-02-25 | HOOK | Fell Below 20 DMA | Bearish |
2021-02-25 | HOOK | Fell Below 50 DMA | Bearish |
2021-02-25 | HTBX | Fell Below 200 DMA | Bearish |
2021-02-25 | ICAD | Fell Below 20 DMA | Bearish |
2021-02-25 | ICAD | New 52 Week High | Strength |
2021-02-25 | ICAD | Wide Range Bar | Range Expansion |
2021-02-25 | IMAB | 20 DMA Support | Bullish |
2021-02-25 | IMAB | Shooting Star Candlestick | Bearish |
2021-02-25 | IMAB | Pocket Pivot | Bullish Swing Setup |
2021-02-25 | INFU | Fell Below 50 DMA | Bearish |
2021-02-25 | IONS | Fell Below 200 DMA | Bearish |
2021-02-25 | KURA | Fell Below 200 DMA | Bearish |
2021-02-25 | MACK | Stochastic Reached Oversold | Weakness |
2021-02-25 | MACK | 1,2,3 Pullback Bullish | Bullish Swing Setup |
2021-02-25 | MDNA | Fell Below 20 DMA | Bearish |
2021-02-25 | MDNA | 50 DMA Resistance | Bearish |
2021-02-25 | MRSN | 180 Bearish Setup | Bearish Swing Setup |
2021-02-25 | MTP | 50 DMA Support | Bullish |
2021-02-25 | MTP | 1,2,3 Pullback Bullish | Bullish Swing Setup |
2021-02-25 | MTP | Non-ADX 1,2,3,4 Bullish | Bullish Swing Setup |
2021-02-25 | MTP | Stochastic Reached Oversold | Weakness |
2021-02-25 | NCNA | MACD Bearish Centerline Cross | Bearish |
2021-02-25 | NCNA | Fell Below 50 DMA | Bearish |
2021-02-25 | NCNA | 200 DMA Support | Bullish |
2021-02-25 | ONCT | Fell Below 20 DMA | Bearish |
2021-02-25 | OPK | Lower Bollinger Band Walk | Weakness |
2021-02-25 | ORIC | 20 DMA Support | Bullish |
2021-02-25 | ORIC | 50 DMA Support | Bullish |
2021-02-25 | PDSB | Fell Below 20 DMA | Bearish |
2021-02-25 | PIRS | Shooting Star Candlestick | Bearish |
2021-02-25 | PIRS | 20 DMA Resistance | Bearish |
2021-02-25 | PIRS | 50 DMA Support | Bullish |
2021-02-25 | PIRS | Fell Below 200 DMA | Bearish |
2021-02-25 | PIRS | Doji - Bearish? | Reversal |
2021-02-25 | PMVP | Fell Below 20 DMA | Bearish |
2021-02-25 | PRLD | MACD Bearish Centerline Cross | Bearish |
2021-02-25 | SLRX | Fell Below 20 DMA | Bearish |
2021-02-25 | SLRX | Calm After Storm | Range Contraction |
2021-02-25 | TLSA | Narrow Range Bar | Range Contraction |
2021-02-25 | TLSA | Lower Bollinger Band Walk | Weakness |
2021-02-25 | TLSA | MACD Bearish Centerline Cross | Bearish |
2021-02-25 | ZYME | 200 DMA Resistance | Bearish |
2021-02-25 | ZYME | Fell Below 20 DMA | Bearish |
Cancer is a group of diseases involving abnormal cell growth with the potential to invade or spread to other parts of the body. These contrast with benign tumors, which do not spread to other parts of the body. Possible signs and symptoms include a lump, abnormal bleeding, prolonged cough, unexplained weight loss and a change in bowel movements. While these symptoms may indicate cancer, they may have other causes. Over 100 types of cancers affect humans.Tobacco use is the cause of about 22% of cancer deaths. Another 10% are due to obesity, poor diet, lack of physical activity or excessive drinking of alcohol. Other factors include certain infections, exposure to ionizing radiation and environmental pollutants. In the developing world, 15% of cancers are due to infections such as Helicobacter pylori, hepatitis B, hepatitis C, human papillomavirus infection, Epstein–Barr virus and human immunodeficiency virus (HIV). These factors act, at least partly, by changing the genes of a cell. Typically, many genetic changes are required before cancer develops. Approximately 5–10% of cancers are due to inherited genetic defects from a person's parents. Cancer can be detected by certain signs and symptoms or screening tests. It is then typically further investigated by medical imaging and confirmed by biopsy.Many cancers can be prevented by not smoking, maintaining a healthy weight, not drinking too much alcohol, eating plenty of vegetables, fruits and whole grains, vaccination against certain infectious diseases, not eating too much processed and red meat and avoiding too much sunlight exposure. Early detection through screening is useful for cervical and colorectal cancer. The benefits of screening in breast cancer are controversial. Cancer is often treated with some combination of radiation therapy, surgery, chemotherapy and targeted therapy. Pain and symptom management are an important part of care. Palliative care is particularly important in people with advanced disease. The chance of survival depends on the type of cancer and extent of disease at the start of treatment. In children under 15 at diagnosis, the five-year survival rate in the developed world is on average 80%. For cancer in the United States, the average five-year survival rate is 66%.In 2015, about 90.5 million people had cancer. About 14.1 million new cases occur a year (not including skin cancer other than melanoma). It caused about 8.8 million deaths (15.7% of deaths). The most common types of cancer in males are lung cancer, prostate cancer, colorectal cancer and stomach cancer. In females, the most common types are breast cancer, colorectal cancer, lung cancer and cervical cancer. If skin cancer other than melanoma were included in total new cancer cases each year, it would account for around 40% of cases. In children, acute lymphoblastic leukemia and brain tumors are most common, except in Africa where non-Hodgkin lymphoma occurs more often. In 2012, about 165,000 children under 15 years of age were diagnosed with cancer. The risk of cancer increases significantly with age, and many cancers occur more commonly in developed countries. Rates are increasing as more people live to an old age and as lifestyle changes occur in the developing world. The financial costs of cancer were estimated at $1.16 trillion USD per year as of 2010.
Mike's Notes
- CGNT: Not a chart ...
- TDOC: One of sever...
- NFLX: I love these...
- CGEM: The Hot IPO ...
- X: A 17% breako...
From the Blog
Popular Now
Featured Articles
- Tech Stock Indices: Do Bulls Have A Problem?
- Robinhood Proxies – The Private and Public Markets Can Be Very Connected
- The Rise of Cult Stocks
- If you don’t know why you’re getting in, it will be even harder to get out
- Three Ways To Make Better Decisions in Markets
- Semi-automating Your Trading
- Recommended Stock Trading Books